Suzanne Bruhn
Direktor/Vorstandsmitglied bei MIND MEDICINE (MINDMED) INC.
Vermögen: 648 245 $ am 30.06.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Ivana Magovcevic-Liebisch | M | 56 | 6 Jahre | |
| Gregg Lapointe | M | 65 |
Raptor Pharmaceuticals Corp.
 Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | 10 Jahre |
| Timothy Walbert | M | 57 |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | 13 Jahre |
| Gary Lyons | M | 73 | 10 Jahre | |
| Jeffrey Meckler | M | 57 | 10 Jahre | |
| Carol Vallone | F | 67 | 3 Jahre | |
| Richard Jack | M | - |
Promedior, Inc.
 Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | 10 Jahre |
| Eric Dube | M | 51 | 5 Jahre | |
| Chris Cline | M | 40 | 10 Jahre | |
| Bernard Coulie | M | 58 | 8 Jahre | |
| Miri Wernli | M | 71 | 4 Jahre | |
| Robert Barrow | M | 35 | 3 Jahre | |
| Ho Young Huh | M | 54 | 7 Jahre | |
| Smital Shah | F | 48 | 5 Jahre | |
| Stefan Vitorovic | M | 39 | 3 Jahre | |
| Samantha Haeberlein | M | - | 1 Jahre | |
| Sandra E. Poole | F | 60 | 5 Jahre | |
| David Pyott | M | 70 | 3 Jahre | |
| John Curnutte | M | 72 | 7 Jahre | |
| Katharine Knobil | M | 60 | 2 Jahre | |
| Mike Ouimette | M | 51 | 4 Jahre | |
| Gerhard Koenig | M | 63 | 4 Jahre | |
| Bill DeGrado | M | - | 9 Jahre | |
| Carole Abel | F | - | - | |
| Christopher Keenan | M | - | 4 Jahre | |
| Mary Jeka | F | - |
EMPath
 EMPath Miscellaneous Commercial ServicesCommercial Services EMPath provides nonprofit programs for women. The non-profit company is based in Boston, MA. | 14 Jahre |
| Roger Crystal | M | 47 | 2 Jahre | |
| Darren Cline | M | 59 | 1 Jahre | |
| Sandra Calvin | F | 59 | 10 Jahre | |
| Elizabeth Reed | F | 53 | 7 Jahre | |
| Mary Thistle | F | 64 | 2 Jahre | |
| Cheryl Blanchard | M | 59 | 4 Jahre | |
| Tim Coughlin | M | 57 | 9 Jahre | |
| Andreas Krebs | M | 65 | 3 Jahre | |
| June Almenoff | M | 67 | 3 Jahre | |
| Gilla Kaplan | M | 76 | 4 Jahre | |
| Gayle Crowell | F | 73 | 4 Jahre | |
| Mark Sullivan | M | 52 | 1 Jahre | |
| Monica Sandberg | M | - | 5 Jahre | |
| Ruth Williams-Brinkley | F | 72 | 3 Jahre | |
| Roy Baynes | M | 69 | 8 Jahre | |
| Bruce Booth | M | 49 | 4 Jahre | |
| Kim Lee | M | - | 10 Jahre | |
| Paul Hoelscher | M | 59 | 8 Jahre | |
| John Orwin | M | 59 | 7 Jahre | |
| Ron Squarer | M | 57 | 7 Jahre | |
| Thomas McCourt | M | 66 | 1 Jahre | |
| Charlotte Smith | F | - | - | |
| Francois Lilienthal | M | - | 2 Jahre | |
| Robert Silva | M | - | 2 Jahre | |
| Rik Derynck | M | - | - | |
| Angela Giannantonio | F | - | - | |
| Casey Logan | M | 52 | 6 Jahre | |
| Carrie Liao | F | 58 | 3 Jahre | |
| Daniel Karlin | M | 44 | 3 Jahre | |
| Madeline Feldman | F | - | - | |
| Peter Heerma | M | 53 | 5 Jahre | |
| Hal Chapman | M | - | 9 Jahre | |
| Dean Sheppard | M | - | 9 Jahre | |
| Hans Hull | M | 49 | 8 Jahre | |
| Bridget Walton | F | - | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Christopher Starr | M | 71 |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | 11 Jahre |
| Georgia Erbez | F | 57 |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | 2 Jahre |
| Stephen Aselage | M | 73 | 10 Jahre | |
| Michael Patrick Smith | M | 55 | 1 Jahre | |
| Julie Smith | F | 53 | - | |
| Graham Hetherington | M | 65 | 6 Jahre | |
| Uli Alf Hacksell | M | 74 | 5 Jahre | |
| Franz Hefti | M | 76 |
Proclara Biosciences, Inc.
 Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | 3 Jahre |
| Kim Tsuchimoto | F | 61 |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | 9 Jahre |
| Simon Pedder | M | 63 | 2 Jahre | |
| James Bowling | M | 56 | 10 Jahre | |
| Llew Keltner | M | 74 | 7 Jahre | |
| Dominick Colangelo | M | 60 |
Promedior, Inc.
Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | 4 Jahre |
| Susan Kilsby | F | 65 | 8 Jahre | |
| Gregory Perry | M | 63 | 1 Jahre | |
| Angus Russell | M | 68 | 14 Jahre | |
| Jeffrey Poulton | M | 56 | 14 Jahre | |
| Vijay Samant | M | 77 |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | 3 Jahre |
| Michael Dennis Price | M | 66 | 3 Jahre | |
| Jason Lettmann | M | 46 |
Promedior, Inc.
Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | 6 Jahre |
| Erich Sager | M | 66 | 6 Jahre | |
| Schond Greenway | M | 52 | 3 Jahre | |
| Sol Barer | M | 76 | 1 Jahre | |
| Cortney Caudill | F | - | 4 Jahre | |
| Phillip Gutry | M | 50 | 6 Jahre | |
| Souheil Salah | M | - | 16 Jahre | |
| Georges Gemayel | M | 63 | 1 Jahre | |
| David John Kappler | M | 76 | 12 Jahre | |
| Illya Keith Maher | M | 56 | 1 Jahre | |
| Tatjana Anni Hilde May | F | 58 | - | |
| Paul McBarron | M | 63 | 5 Jahre | |
| Cynthia Hu | M | 54 | 2 Jahre | |
| V. Lawlis | M | 72 | 5 Jahre | |
| Maxim Jacobs | M | - | - | |
| Brigid Makes | F | 68 | 4 Jahre | |
| David Stout | M | 70 | 6 Jahre | |
| Charles Homcy | M | 75 | 7 Jahre | |
| Keith W. Schmidt | M | 74 | 1 Jahre | |
| Ian Karp | M | - | 5 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 71 | 71,00% |
| Kanada | 19 | 19,00% |
| Irland | 11 | 11,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Suzanne Bruhn
- Persönliches Netzwerk
